Image

Interest of a Weekly Consultation by a Medical Electro Radiology Manipulator (MERM) in Addition to the Follow-up by the Radiotherapist to Improve the Collection of Radio-induced Toxicities in Patients Undergoing Proton Therapy

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

To our knowledge, the investigators have not found any scientific article dealing with cooperation between radiation oncologists and medical radiation technologists in the context of monitoring patients undergoing radiotherapy. Cooperation protocols between health professionals are in progress but concern mainly technical procedures (ultrasound, laserthermal sessions).

This study aims to evaluate whether MERMs, after training by physicians, can monitor clinical signs (for usual well-described toxicities) during treatment via a dedicated consultation.

This approach participates in the development of new professions and cooperation protocols between health professionals. This mission of accompaniment on a dedicated time would make it possible to develop the caring role of the medical electroradiology manipulator.

Eligibility

Inclusion Criteria:

  • Patient > 18 years;
  • Patient with malignant or benign brain or upper aerodigestive tract (ADT) tumor candidate for proton therapy;
  • WHO score < 2
  • Mastery of the French language;
  • Patient affiliated with a social security system;
  • Signature of informed consent prior to any specific procedure related to the study.

Exclusion Criteria:

  • Patient with another cancer previously treated with radiation therapy;
  • Simultaneous participation in a therapeutic clinical trial;
  • Patient deprived of liberty or under guardianship;
  • Any associated medical or psychological condition that may compromise the patient's ability to participate in the study
  • Patient unable to undergo trial monitoring for geographical, social or psychopathological reasons.

Study details

Paramedical Consultation, Radiotherapy, Proton Therapy, Brain Tumor

NCT05404308

Centre Francois Baclesse

8 June 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.